Dosing & Uses
Type 1 Diabetes Mellitus
Allogeneic pancreatic islet cellular therapy pending FDA approval for treatment of brittle type 1 diabetes mellitus (labile diabetes; brittle T1D) in adults whose symptoms are not well controlled despite intensive insulin therapy
Next:
Pharmacology
Mechanism of Action
Allogeneic pancreatic islet cellular therapy that provides transplanted islets from donated pancreata from deceased organ donors
Pancreatic islets regulate blood glucose levels through highly regulated, pulsatile secretion of multiple hormones in response to fluctuations in blood glucose; endocrine cells within pancreatic islets release insulin, glucagon, somatostatin, pancreatic peptide, and ghrelin
Previous
Next:
Images
Previous
Next:
Patient Handout
Previous
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.
